Esperovax
PrivateLast Round
Grant
Dec 12, 2024
Total Funding Raised
$3.41M
Company Overview
Esperovax is a biotechnology company that has developed a novel mRNA oral vaccine platform to enable large-scale production and distribution of shelf-stable vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Esperovax Comparables
Compare Esperovax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fzata, Inc. | 82% | |
| iosBio | 79% | |
| GIVAX | 75% | |
Esperovax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2024 | ||||
| Grant | Aug 23, 2023 | ||||
| Seed | Apr 29, 2021 | ||||
| Convertible Debt | Apr 9, 2021 | ||||
| Convertible Debt | Jan 19, 2021 | ||||
Grant | Sep 23, 2020 |
Esperovax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Michigan Angels | Seed |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Michigan Rise | Convertible Debt, Seed |
| Michigan Strategic Fund | Convertible Debt |
| Johnson & Johnson Innovation - JLABS | Grant |
| Defense Threat Reduction Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2026
Monthly visitors grew 80% MoM, from 670 to 1.2K.
- May 1, 2025
Monthly visitors increased 907% to 1.4K.
Esperovax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Esperovax's valuation, stock price, and market status.